Serotonin Inhibitors and Risk of Dental Implant Failure

Relationship between Selective Serotonin Reuptake Inhibitors and Risk of Dental Implant Failure
To identify associations between implant failure and selective serotonin reuptake inhibitor (SSRI) medication use in a cohort of consecutive patients receiving dental implants during a 20‐year period.
In the population reviewed, a history of sertraline use was associated with a 60% greater risk of implant failure; however, active SSRI use at the time of implant placement or during follow‐up was not significantly associated with an increased risk of implant failure.
Author(s) Source
Carr AB, Gonzalez RLV, Jia L, Lohse CM Journal of Prosthodontics, 13. Jan 2019, https://doi.org/10.1111/jopr.13015
This is a post of a scientific or business information. The information given here is checked thoroughly by “Implant-Register”. However we can´t be responsible for the content. Contact the publisher, if you have questions. You may inform us about changes of the information to improve the Register.
Comments: n/a
let us know

COVID-19
news

stay connected

don’t miss any news of the
Implant-Register,
tailored to your preferences

                                  GET IT!

Scroll to Top